Stay updated on UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Sign up to get notified when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.

Latest updates to the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page
- Check2 days agoChange DetectedA site-wide notice announces a transition in NIH content from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check8 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check15 days agoChange DetectedThe site footer revision changed from v3.7.0 to v3.7.1 while the page continued to display a 403 Forbidden error.SummaryDifference0.2%

- Check36 days agoChange DetectedThe page now displays a 403 Forbidden error screen, indicating access is blocked to the study record, with the site header and footer visible as part of the error layout.SummaryDifference17%

- Check58 days agoChange DetectedThe site's revision label was updated to v3.6.6, signaling a new platform release. This update does not change study data or visible content on the page.SummaryDifference0.1%

- Check65 days agoChange DetectedA new item appears under Other Study ID Numbers showing '2016 ( U.S. NIH Grant/Contract )', adding an NIH funding/identifier reference to the study record. This entry adds administrative funding information tied to the trial.SummaryDifference0.1%

Stay in the know with updates to UCART19 Dose Escalation Study in B-cell ALL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UCART19 Dose Escalation Study in B-cell ALL Clinical Trial page.